Table 2 Treatments during the first 7 days.

From: Multicenter randomized trial assessing efficacy and safety of aerosolized dornase Alfa in COVID-19 ARDS

n/N (%)

CONTROL (N = 38)

EXPERIMENTAL (N = 39)

p value

Any prone position

30/37 (81%)

26/38 (68%)

0.2a

Any tocilizumab

0/33 (0%)

1/36 (3%)

> 0.9b

Any steroids

32/36 (89%)

33/39 (85%)

0.7b

Any antibiotics

36/38 (95%)

35/37 (95%)

> 0.9b

  1. a Chi2 test. b Fisher exact test.
Back to article page